Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 01, 2026, titled "Sun Pharma Participates in White House Signing Ceremony Highlighting U.S. Medicines Pricing and Access Commitments".
Sun Pharmaceutical Industries Limited Press Release Sep 01 2026
Filed with NSE · · 3 pages · English
Release
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Limited Press Release Jul 29 2026
- Sun Pharmaceutical Industries Limited Press Release Jul 24 2026
- Sun Pharmaceutical Industries Limited Press Release Jul 15 2026
- American Skin Association annual gala recognizes Sun Pharma with corporate leadership award
- At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT™ (cosibelimab-ipdl)
Later from Sun Pharmaceutical Industries
- Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
- First-Ever Standardized U.S. Treatment Recommendations Issued for Adults with Severe Alopecia Areata; Sun Pharma Welcomes Milestone
- Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
- Sun Pharmaceutical Industries Limited Press Release Sep 28 2026
- LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a Novel PCSK9 Inhibitor, Ex-US and China; Lerodalcibep (Lyrokaul®) Approved in the EU
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries